You just read:

Updated St. Gallen International Breast Cancer Guidelines, for the Second Time, Recognize Oncotype DX® as the Only Validated Multi-Gene Test Able to Predict Chemotherapy Benefit

News provided by

Genomic Health, Inc.

23 Aug, 2013, 07:00 BST